Established Pharmaceuticals — Additions to Property and Equipment
Abbott Established Pharmaceuticals — Additions to Property and Equipment decreased by 66.1% to $20.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 39.4%, from $33.00M to $20.00M. Over 4 years (FY 2021 to FY 2025), Established Pharmaceuticals — Additions to Property and Equipment shows relatively stable performance with a 0.0% CAGR.
Analysis
How to read this metric
An increase suggests management is investing in future production capacity or facility upgrades, while a decrease may indicate a focus on capital preservation or a shift toward asset-light operations.
Detailed definition
This metric tracks the capital expenditures directed toward the Established Pharmaceuticals segment to acquire, upgrade,...
Peer comparison
Comparable to 'Capital Expenditures' or 'Additions to Property, Plant, and Equipment' reported by other pharmaceutical companies for specific business units.
abt_segment_established_pharmaceuticals_additions_to_property_and_equipmentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.25M | $42.25M | $42.25M | $43.75M | $43.75M | $43.75M | $43.75M | $46.25M | $46.25M | $46.25M | $46.25M | $29.00M | $37.00M | $52.00M | $65.00M | $33.00M | $39.00M | $38.00M | $59.00M | $20.00M |
| QoQ Change | — | +0.0% | +0.0% | +3.6% | +0.0% | +0.0% | +0.0% | +5.7% | +0.0% | +0.0% | +0.0% | -37.3% | +27.6% | +40.5% | +25.0% | -49.2% | +18.2% | -2.6% | +55.3% | -66.1% |
| YoY Change | — | — | — | — | +3.6% | +3.6% | +3.6% | +5.7% | +5.7% | +5.7% | +5.7% | -37.3% | -20.0% | +12.4% | +40.5% | +13.8% | +5.4% | -26.9% | -9.2% | -39.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's established pharmaceuticals — additions to property and equipment?
- Abbott (ABT) reported established pharmaceuticals — additions to property and equipment of $20.00M in Q1 2026.
- How has Abbott's established pharmaceuticals — additions to property and equipment changed year-over-year?
- Abbott's established pharmaceuticals — additions to property and equipment decreased by 39.4% year-over-year, from $33.00M to $20.00M.
- What is the long-term trend for Abbott's established pharmaceuticals — additions to property and equipment?
- Over 4 years (2021 to 2025), Abbott's established pharmaceuticals — additions to property and equipment has grown at a 0.0% compound annual growth rate (CAGR), from $169.00M to $169.00M.
- What does established pharmaceuticals — additions to property and equipment mean?
- The amount of money invested in physical assets and infrastructure specifically for the Established Pharmaceuticals business segment.